KINGDON CAPITAL MANAGEMENT, L.L.C. Cara Therapeutics, Inc. Transaction History

KINGDON CAPITAL MANAGEMENT, L.L.C. portfolio value:

$0
portfolio value

Cara Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 call Decrease -100.00% -150K shares -1.37M $9.36 0
Q3 2022 share Increase +12.68% 150K shares 1.67M $9.36 1.33M
Q2 2022 share 0.00% 0 shares -3.57M $9.13 1.18M
Q2 2022 call Increase 0.00% 150K shares 1.37M $9.13 150K
Q1 2022 share Increase +33.98% 300K shares 3.61M $12.15 1.18M
Q4 2021 share Increase +23.38% 167.31K shares -302K $12.34 883K
Q3 2021 share Increase +65.60% 283.50K shares 4.89M $15.45 715.68K
Q2 2021 share Decrease -40.52% -294.40K shares -9.60M $14.27 432.17K
Q1 2021 share Increase +15.96% 100K shares 6.29M $21.71 726.58K
Q4 2020 share 0.00% 0 shares 1.50M $15.13 626.58K
Q3 2020 share 0.00% 0 shares -2.74M $12.73 626.58K
Q2 2020 call Decrease -100.00% -144.7K shares -1.91M $17.1 0
Q2 2020 share Increase +30.03% 144.7K shares 4.34M $17.1 626.58K
Q1 2020 share Increase +2.19% 10.30K shares -1.23M $13.21 481.88K
Q1 2020 call Increase 0.00% 144.7K shares 1.91M $13.21 144.7K
Q4 2019 share Increase +67.34% 189.76K shares 2.44M $16.11 471.57K
Q3 2019 share Increase +40.55% 81.30K shares 840K $18.28 281.80K
Q2 2019 share Increase 0.00% 200.5K shares 4.31M $21.5 200.5K
Q3 2017 call Decrease -100.00% -16.5K shares -254K $13.69 0
Q2 2017 call Increase 0.00% 16.5K shares 254K $15.39 16.5K